Cardiomegaly
Showing 51 - 75 of 275
Peripheral T-cell Lymphoma, Cutaneous T-cell Lymphoma Trial in Japan (E7777)
Completed
- Peripheral T-cell Lymphoma
- Cutaneous T-cell Lymphoma
-
Nagoya, Aichi, Japan
- +19 more
Jun 24, 2021
Critical Limb Ischemia Trial in Worldwide (Lutonix DCB, Uncoated PTA Catheter)
Completed
- Critical Limb Ischemia
- Lutonix DCB
- Uncoated PTA Catheter
-
New Haven, Connecticut
- +50 more
Feb 3, 2022
Tumor Malignant Trial in Worldwide (SAR245408, SAR245409)
Completed
- Neoplasm Malignant
-
Birmingham, Alabama
- +20 more
Mar 30, 2022
Uveal Melanoma Trial in Worldwide (IMCgp100)
Active, not recruiting
- Uveal Melanoma
-
La Jolla, California
- +25 more
Mar 10, 2022
Glioblastoma Multiforme Trial in Worldwide (drug, other, radiation)
Terminated
- Glioblastoma Multiforme
- Steroid eye drops
- +6 more
-
Los Angeles, California
- +21 more
Mar 19, 2021
Boostrix Vaccine Given According to Prescribing Information in
Completed
- Diphtheria-Tetanus-acellular Pertussis Vaccines
- Boostrix
- Safety data collection
-
Suwon-si, Korea, Republic ofGSK Investigational Site
Sep 11, 2019
Cardiac Surgery, Sternal Wound Infection Trial in United States (gentamicin-collagen sponge dipped in saline)
Completed
- Cardiac Surgery
- Sternal Wound Infection
- gentamicin-collagen sponge dipped in saline
-
Birmingham, Alabama
- +42 more
May 4, 2022
Ischemic Stroke Trial in United States (intravenous (IV) recombinant human tissue plasminogen activator (rtPA), Penumbra System)
Completed
- Ischemic Stroke
- intravenous (IV) recombinant human tissue plasminogen activator (rtPA)
- Penumbra System
-
Denver, Colorado
- +3 more
Sep 18, 2020
Thalassemia Trial in Houston (Busulfan, Fludarabine, Campath 1H)
Primary Hypercholesterolemia, Mixed Dyslipidemia Trial in China (evolocumab, )
Terminated
- Primary Hypercholesterolemia
- Mixed Dyslipidemia
- evolocumab
- placebo
-
Beijing, Beijing, China
- +30 more
Oct 7, 2021
Influenza A Trial in Worldwide (Pimodivir 600 mg, Placebo, SOC Treatment)
Terminated
- Influenza A
- Pimodivir 600 mg
- +2 more
-
Birmingham, Alabama
- +269 more
Mar 19, 2021
Lung Ultrasound in PD Patients
Completed
- Peritoneal Dialysis
- +2 more
- NT-BNP, VEGF
- +4 more
-
Istanbul, TurkeyMustafa Sevinc
Mar 31, 2020
Proliferative Diabetic Retinopathy, Vitreous Hemorrhage Trial in Canada, United States (2-mg Intravitreous Aflibercept
Completed
- Proliferative Diabetic Retinopathy
- Vitreous Hemorrhage
- 2-mg Intravitreous Aflibercept Injection
- Prompt Vitrectomy Plus Panretinal Photocoagulation
-
Campbell, California
- +61 more
Mar 24, 2021
Advanced Solid Tumors, Carcinoid, Colorectal Cancer Trial in Poland, Spain, United States (Modified FOLFOX6, Conatumumab,
Completed
- Advanced Solid Tumors
- +8 more
- Modified FOLFOX6
- +3 more
-
Duarte, California
- +11 more
Feb 3, 2021
Primary Immunodeficiency Disease Trial in United States (Kedrion IVIG 10%)
Completed
- Primary Immunodeficiency Disease
- Kedrion IVIG 10%
-
North Palm Beach, Florida
- +10 more
Jan 26, 2022
Respiratory Syncytial Virus Infections Trial in Worldwide (RSV MAT 60 µg, RSV MAT 120 µg, Placebo)
Completed
- Respiratory Syncytial Virus Infections
- RSV MAT 60 µg
- +2 more
-
Phoenix, Arizona
- +31 more
Nov 12, 2021
Pain Associated With Fibromyalgia Trial in Worldwide (DS-5565, Pregabalin, Placebo tablet)
Hepatomegaly, Myelofibrosis Transformation in Essential Thrombocythemia, Polycythemia Vera, Post-Polycythemic Myelofibrosis
Terminated
- Hepatomegaly
- +4 more
- Laboratory Biomarker Analysis
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Apr 23, 2019
Aortic Valve Stenosis Trial in Minneapolis, Cincinnati (External beam radiation therapy, Sham Control)
Terminated
- Aortic Valve Stenosis
- External beam radiation therapy
- Sham Control
-
Minneapolis, Minnesota
- +1 more
Sep 30, 2019
Cystitis, Interstitial Trial in United States (PF-04383119, Placebo)
Non-Small-Cell Lung Carcinoma NSCLC Trial in Worldwide (MEDI4736 (Durvalumab), MEDI4736 (Durvalumab)+Tremelimumab, Paclitaxel +
Active, not recruiting
- Non-Small-Cell Lung Carcinoma NSCLC
- MEDI4736 (Durvalumab)
- +7 more
-
Scottsdale, Arizona
- +198 more
Jul 12, 2022
Diabetic Macular Edema Trial in United States (2.0 mg intravitreal aflibercept, 1.25 mg intravitreal bevacizumab, 0.3 mg
Completed
- Diabetic Macular Edema
- 2.0 mg intravitreal aflibercept
- +2 more
-
Tucson, Arizona
- +89 more
Jul 22, 2020